LCM
ZEAL

Laurion Capital Management’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Laurion Capital Management’s Portfolio ZEAL Stock Details ZEAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-16,617
Closed -$250K – 1670
2018
Q1 		$250K Sell
16,617
-58,483
-78% -$908K ﹤0.01% 1180
2017
Q4 		$1.02M Sell
75,100
-1,100
-1% -$17.3K 0.01% 961
2017
Q3 		$1.46M Buy
+76,200
New +$1.44M 0.01% 858

Other funds holding ZEAL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Laurion Capital Management's ZEAL Position: Q2 2018 in Review

Laurion Capital Management sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q2 2018, closing a stake of 16,617 shares — an estimated $250K sold.

Laurion Capital Management first reported a position in ZEAL in Q3 2017 and held it in 3 quarters. The position peaked at $1.46M in Q3 2017. 11 funds tracked by Wall St. Rank hold ZEAL as of Q2 2018.

  • Laurion Capital Management reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q2 2018 after selling out during the quarter.
  • Laurion Capital Management sold 16,617 Zealand Pharma A/S American Depositary Shares shares in Q2 2018, an estimated $250K.
  • Laurion Capital Management first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 3 quarters.
  • Laurion Capital Management's Zealand Pharma A/S American Depositary Shares position peaked at $1.46M in Q3 2017.
  • 11 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q2 2018.

Based on Laurion Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.